Evaluating the Prevalence of Non-Communicable Diseases Among HIV Positive Individuals in Chingola District, Zambia

Download Article

DOI: 10.21522/TIJPH.2013.14.01.Art017

Authors : Judith Musonda

Abstract:

The study was aimed at evaluating the prevalence of non-communicable diseases among HIV positive individuals in Chingola District, Zambia. The widespread success of antiretroviral therapy (ART) has caused HIV to change from an acute to a chronic illness. Although the life expectancy of people living with HIV (PLHIV) has increased dramatically as a result of this advancement, new health issues have also emerged, most notably the increased prevalence of non-communicable diseases (NCDs) in this population. HIV-positive people are increasingly being diagnosed with noncommunicable diseases (NCDs), including diabetes, hypertension, cardiovascular disease, and chronic respiratory conditions. The study was carried out in Zambia's Copperbelt Province's Chingola District. Purposively, five of the district's largest antiretroviral therapy (ART) clinics were chosen based on patient volume and accessibility. Between January and May of 2025, a descriptive cross-sectional study was carried out involving 500 participants. The results show that most prevalent non-communicable disease among the 500 HIV-positive people was hypertension, which affected 268 participants i.e. 53.58% of the sample. The analysis identified predictors of non-communicable diseases (NCDs) include age which had the odds of having an NCD increased by 5% for every year, indicating that age was a significant factor (OR = 1.05, 95% CI: 1.03–1.08, p < 0.001). The study concludes that there is a significant burden of non-communicable diseases (NCDs) among people living with HIV (PLHIV) in the district.

References:

[1] Althoff, K. N., et al., 2019, "HIV and aging: State of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group." Journal of Acquired Immune Deficiency Syndromes, 81(1), 1-12.

[2] World Health Organization, Country Disease Outlook - Zambia. Date of access: 20/05/2025 https://www.afro.who.int/sites/default/files/2023-08/Zambia.pdf

[3] Machalaba, C., et al., 2023, "Cardiovascular disease risk factors and outcomes in people living with HIV: A systematic review and meta-analysis." The Lancet HIV, 10(1), e32-e44.

[4] UNAIDS, Global AIDS Update 2023. Date of access: 20/05/2025 https://www.unaids.org/en/resources/documents/2023/global-aids-update

[5] Nduka, C. U., Stranges, S., Sarki, A. M., Kimani, P. K., & Uthman, O. A., 2020, Evidence of increased risk of non-communicable diseases in HIV-positive populations in sub-Saharan Africa: A systematic review and meta-analysis. PLOS ONE, 15(8), e0237420. https://doi.org/10.1371/journal.pone.0237420

[6] Rabkin, M., Nishtar, S., & Besada, D., 2018, Integrated care for chronic conditions: the global challenge to achieve health equity. Health Affairs, 37(3), 408–412. https://doi.org/10.1377/hlthaff.2017.1393

[7] Shah, A. S., 2020, "Non-communicable diseases and HIV care and treatment: Models of integrated service delivery." Tropical Medicine & International Health, 25(3), 298-305.

[8] Triant, V. A., 2023. "Cardiovascular disease and HIV infection." Nature Reviews Cardiology, 20(1), 33 -45.

[9] Mudenda, S., Mukosha, M., & Fwoloshi, S. 2019, Prevalence of hypertension and diabetes mellitus among people living with HIV/AIDS on antiretroviral therapy. Medical Journal of Zambia, 46(2), 85–90.

[10] Mutagonda, R. F., Siril, H., Kaaya, S., 2022, Prevalence and determinants of non-communicable diseases including depression among HIV patients on antiretroviral therapy in Dar es Salaam, Tanzania. Trop Med Int Health, 27:742–51

[11] World Health Organization, 2021, Noncommunicable diseases: Key facts. Date of access: 2/06/2025 https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

[12] Zambia Ministry of Health, 2021, Zambia Population-based HIV Impact Assessment (ZAMPHIA) Report.

[13] Chanda-Kapata, P., Klinkenberg, E., Maddox, N., & Kapata, N, 2016, Health seeking behaviour among individuals with presumptive tuberculosis in Zambia. PLOS ONE, 11(3), e0149336. https://doi.org/10.1371/journal.pone.0149336

[14] Hamoonga, B. M., Tsarkov, A., Petlovanyi, P., Marinda, P. A., Kumwenda, C., Oguta, T. J., Phiri, C., 2023, Prevalence and incidence of hypertension and diabetes mellitus among HIV-infected individuals receiving HAART in Chongwe District, Lusaka Province, Zambia. European Journal of Clinical Medicine, 1(2) 45- 64.

[15] Moyo-Chilufya, M., Maluleke, K., Kgarosi, K., Muyoyeta, M., Hongoro, C., & Musekiwa, A., 2023, The burden of non‑communicable diseases among people living with HIV in Sub‑Saharan Africa: A systematic review and meta‑analysis. eClinicalMedicine, 65, 102255. https://doi.org/10.1016/j.eclinm.2023.102255

[16] Nduka, C. U., Stranges, S., Sarki, A. M., Kimani, P. K., & Uthman, O. A., 2017, Evidence of increased cardiometabolic risk in HIV-positive individuals receiving antiretroviral therapy: A systematic review and meta-analysis. PLOS ONE, 12(4), e0173936. https://doi.org/10.1371/journal.pone.0173936

[17] Zambia Ministry of Health, 2021, Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection. Lusaka: MoH.

[18] Henderson, K. L., 2023, "Long-term effects of integrase inhibitors on bone health: A prospective cohort study." Journal of Bone and Mineral Research, 38(4), 725-736.

[19] Ibrahim, N., 2022, "Digital health interventions for integrated HIV-NCD care: A randomized controlled trial in South Africa." The Lancet Digital Health, 4(6), e429-e438.

[20] Johnson, P. R., & Smith, A. B, 2023, "Cost-effectiveness of integrated care models for HIV and NCDs in resource-limited settings." Health Policy and Planning, 38(5), 567-579.

[21] Kang, Y. J., 2023, "Novel biomarkers for early detection of cardiovascular disease in HIV-positive individuals." Nature Medicine, 29(3), 312-324.

[22] Liu, H, 2022, "Epigenetic alterations in chronic HIV infection: Implications for aging and disease." Cell Host & Microbe, 30(4), 534-547.

[23] Morrison, T. A., 2023, "Exercise interventions for HIV-associated metabolic syndrome: A metaanalysis." Sports Medicine, 53(2), 245-262.